openPR Logo
Press release

Mycoplasma Testing Market to Witness Huge Growth by Key Players: Lonza Group Ltd, Merck KGaA, Roche Diagnostics, American Type Culture Collection, InvivoGen, PromoCell GmbH

06-03-2022 02:36 PM CET | Industry, Real Estate & Construction

Press release from: ReportsnReports

The Mycoplasma Testing Market research report strategically profiles key players and comprehensively analyzes their market position in terms of ranking and core competencies, and details the competitive landscape for market leaders. The report also presents the market competition landscape and a corresponding detailed analysis of the major vendors/manufacturers in the market. Moreover, the market report will also assist to understand customer purchasing behaviours in order to grow your brand and gain a foothold in the industry.

Download FREE Sample Research Report of Mycoplasma Testing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=393690

The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period.

The report provides a comprehensive analysis of company profiles listed below:
• Thermo Fisher Scientific, Inc. (US)
• Charles River Laboratories International, Inc. (US)
• Lonza Group Ltd. (Switzerland)
• Merck KGaA (Germany)
• Roche Diagnostics (Switzerland)
• American Type Culture Collection (US)
• Bionique Testing Laboratories, Inc. (US)
• InvivoGen (US)
• PromoCell GmbH (Germany)
• Biological Industries Israel Beit Haemek Ltd. (Israel)
• Creative Bioarray (US)
• Mycoplasma Experience (UK)
• NorgenBiotek Corp. (Canada)
• Agilent Technologies (US)
• Biotools B & M Labs, S.A. (Spain)
• Eurofins Scientific (Luxembourg)
• GeneCopoeia, Inc. (US)
• GenBio (Canada)
• Minerva Biolabs GmbH (Germany)
• Meridian Bioscience, Inc. (US)
• Sartorius AG (Germany)
• Savyon Diagnostics (Israel)
• Nelson Laboratories Fairfield, Inc. (US)
• Clongen Laboratories,LLC (US)
• ScienCell Research Laboratories, Inc. (Canada).

"The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period "
The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service. In 2019, the assays, kits,& reagents segment accounted for this market's largest share. The frequent purchase of these consumables compared to instruments and the increasing use of kit-based techniques for mycoplasma testing are the important factors driving the growth of this market segment.

"Cell line testing segment accounted for the highest CAGR"
Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing. In 2019, the cell line testing segment accounted for the largest share of this market. Factors such as the rapid growth in the biopharmaceutical industry and the increasing demand for monoclonal antibodies drive this market segment's growth.

"Asia Pacific: The fastest-growing region mycoplasma testing market"
The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the expansion of key market players in emerging Asian countries, increasing expenditure on life science research in the region, and the increasing trend of pharmaceutical outsourcing to Asian countries such as India and China.

Special Offers (Buy this report and Get 20% Off) @ https://www.reportsnreports.com/contacts/discount.aspx?name=393690

Competitive Landscape of Mycoplasma Testing Market:
1 Overview
2 Mycoplasma Testing Market Share Analysis
3 Company Evaluation Quadrant
3.1 Definition And Methodology
3.2 Vendor Dive Overview
3.2.1 Stars
3.2.2 Emerging Leaders
3.2.3 Pervasive
3.2.4 Participants
4 Competitive Scenario
4.1 Product/Service Launches
4.2 Partnerships, Agreements, And Collaborations
4.3 Acquisitions
4.4 Expansions

Research Coverage:
This report provides a detailed picture of the global mycoplasma testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product,technique, application,end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

#Customization Service of the Report:
ReportsnReports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Ask Question @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=393690

ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013
PHONE:+ 1 888 391 5441
EMAIL: sales@reportsandreports.com

About Us:-
ReportsnReports provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mycoplasma Testing Market to Witness Huge Growth by Key Players: Lonza Group Ltd, Merck KGaA, Roche Diagnostics, American Type Culture Collection, InvivoGen, PromoCell GmbH here

News-ID: 2644545 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Mycoplasma

Mycoplasma Testing Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Mycoplasma Testing Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Mycoplasma Testing market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of
Swine Mycoplasma Pneumonia Live Vaccine Market: Market for Live Vaccines Designe …
Global Swine Mycoplasma Pneumonia Live Vaccine Market Overview: The Swine Mycoplasma Pneumonia Live Vaccine market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Swine Mycoplasma Pneumonia Live Vaccine market has experienced significant growth, driven by factors such as increasing consumer demand,
Mycoplasma Testing Market : Research Observes Strong CAGR Development
Zion Market Research analysts forecast the latest report on "Global Mycoplasma Testing Market Set For Rapid Growth, To Reach Around USD 1,347.6 Million by 2025", according to their latest report the Mycoplasma Testing Market report covers the overall and all-inclusive analysis of the Mycoplasma Testing Market with all its factors that have an impact on market growth. The Mycoplasma Testing Market's complete outline is crystal clear penned down in the
Mycoplasma Plate Antigen Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Mycoplasma Plate Antigen Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Mycoplasma Plate Antigen players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Mycoplasma Plate Antigen with respect
Mycoplasma Detection Systems Market Trends and Segments 2018-2027
Global Mycoplasma Testing Market: Snapshot In the biopharmaceutical industry, mycoplasmas are typical contaminants of cell cultures. Although they do not result in visible changes in the culture, their numbers could increase rapidly. They are not easily detected either. The conventional methods of mycoplasma DNA detection can soak up a lot of time and is labor-intensive too. To overcome the problem, players in the mycoplasma testing market are coming up with better
Global Mycoplasma Diagnostics Market Analysis
Albany, New York, May 3, 2017: This report on Mycoplasma Diagnostics Studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various mycoplasma techniques and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of